Cargando…

Improving the operational efficiency of Phase 2 and 3 trials

The period toward the end of patients’ participation in late stage blinded clinical trials is highly resource intensive for the sponsor. Consider first a Phase 3 trial. If the trial is a success, the sponsor has to implement the next steps, which might be filing for approval of the drug with the US...

Descripción completa

Detalles Bibliográficos
Autor principal: Ganju, Jitendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955134/
https://www.ncbi.nlm.nih.gov/pubmed/27439520
http://dx.doi.org/10.1186/s13063-016-1465-3